Cardiac tamponade in the fibrinolytic era: Analysis of >100 000 patients with ST-segment elevation myocardial infarction

American Heart Journal

Volumn 151, Issue 2, 2006, Pages 316-322

  Patel, Manesh R ^a   Meine, Trip J ^a   Lindblad, Lauren ^a   Griffin, Jeffrey ^a   Granger, Christopher B ^a   Becker, Richard C ^a   Van De Werf, Frans ^b   White, Harvey ^c   Califf, Robert M ^a   Harrington, Robert A ^a  

^a DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^c GREEN LANE HOSPITAL   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ALTEPLASE; ENOXAPARIN; FIBRINOLYTIC AGENT; HEPARIN; HIRUDIN; HIRULOG; RETEPLASE; STREPTOKINASE; TENECTEPLASE;

ADULT; AGED; ANGIOGRAPHY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE REGIMEN; FEMALE; FIBRINOLYTIC THERAPY; HEART ARRHYTHMIA; HEART INFARCTION; HEART TAMPONADE; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPOTENSION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REPERFUSION; ST SEGMENT ELEVATION;

AGE FACTORS; AGED; ANALYSIS OF VARIANCE; CARDIAC TAMPONADE; CORONARY ANGIOGRAPHY; DATABASES, FACTUAL; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROPORTIONAL HAZARDS MODELS; RANDOMIZED CONTROLLED TRIALS; SEX FACTORS; THROMBOLYTIC THERAPY;

EID: 31344459904     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2005.04.014     Document Type: Article

References (17)

1. S.G. Reddy, and W.C. Roberts Frequency of rupture of the left ventricular free wall or ventricular septum among necropsy cases of fatal acute myocardial infarction since introduction of coronary care units Am J Cardiol 63 1989 906 911
2. P.J. Pappas, A.C. Cernaianu, and W.A. Baldino Ventricular free-wall rupture after myocardial infarction. Treatment and outcome Chest 99 1991 892 895
3. M.H. Raitt, C.D. Kraft, and C.J. Gardner Subacute ventricular free wall rupture complicating myocardial infarction Am Heart J 126 1993 946 955
4. R.C. Becker, J.M. Gore, and C. Lambrew A composite view of cardiac rupture in the United States National Registry of Myocardial Infarction J Am Coll Cardiol 27 1996 1321 1326
5. S. Mohammad, and S.M. Austin Hemopericardium with cardiac tamponade after intravenous thrombolysis for acute myocardial infarction Clin Cardiol 19 1996 432 434
6. M.B. Honan, F.E. Harrell Jr, and K.A. Reimer Cardiac rupture, mortality and the timing of thrombolytic therapy: a meta-analysis J Am Coll Cardiol 16 1990 359 367
7. The GUSTO investigators An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction N Engl J Med 329 1993 673 682
8. The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO III) Investigators A comparison of reteplase with alteplase for acute myocardial infarction N Engl J Med 337 1997 1118 1123
9. Assessment of the Safety and Efficacy of a New Thrombolytic Investigators Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial Lancet 354 1999 716 722
10. Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT)-3 Investigators Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarction Lancet 358 2001 605 613
11. L. Wallentin, P. Goldstein, and P.W. Armstrong Efficacy and safety of tenecteplase in combination with the low-molecular-weight heparin enoxaparin or unfractionated heparin in the prehospital setting: the Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT)-3 PLUS randomized trial in acute myocardial infarction Circulation 108 2003 135 142
12. H. White Hirulog and Early Reperfusion or Occlusion (HERO)-2 Trial Investigators Thrombin-specific anticoagulation with bivalirudin versus heparin in patients receiving fibrinolytic therapy for acute myocardial infarction: the HERO-2 randomised trial Lancet 358 2001 1855 1863
13. The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) IIb investigators A comparison of recombinant hirudin with heparin for the treatment of acute coronary syndromes N Engl J Med 335 1996 775 782
14. The GUSTO Angiographic Investigators The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction N Engl J Med 329 1993 1615 1622
15. R.M. Califf, K.S. Pieper, and K.L. Lee Prediction of 1-year survival after thrombolysis for acute myocardial infarction in the global utilization of streptokinase and TPA for occluded coronary arteries trial Circulation 101 2000 2231 2238
16. E. Correale, A.P. Maggioni, and S. Romano Comparison of frequency, diagnostic and prognostic significance of pericardial involvement in acute myocardial infarction treated with and without thrombolytics. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI) Am J Cardiol 71 1993 1377 1381
17. R. Moreno, J. Lopez-Sendon, and E. Garcia Primary angioplasty reduces the risk of left ventricular free wall rupture compared with thrombolysis in patients with acute myocardial infarction J Am Coll Cardiol 39 2002 598 603